Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Colorectal Neoplasms

Free Subscription 21.10.2019 1 Am J Surg 4 Ann Surg 2 Ann Surg Oncol 1 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 4 Cancer Lett 3 Gastroenterology 2 Gut 1 Int J Cancer 1 J Clin Oncol 1 J Surg Oncol 1 Lancet Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. CARMICHAEL H, Cowan M, McIntyre R, Velopulos C, et al
   Disparities in colorectal cancer mortality for rural populations in the United States: Does screening matter?
   Am J Surg. 2019 Sep 26. pii: S0002-9610(19)30109.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg

2. BRUDVIK KW, Jones RP, Giuliante F, Shindoh J, et al
   RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
   Ann Surg. 2019;269:120-126.
   PubMed     Text format     Abstract available
   
   
3. PETERSSON J, Koedam TW, Bonjer HJ, Andersson J, et al
   Bowel Obstruction and Ventral Hernia After Laparoscopic Versus Open Surgery for Rectal Cancer in A Randomized Trial (COLOR II).
   Ann Surg. 2019;269:53-57.
   PubMed     Text format     Abstract available
   
   
4. HABR-GAMA A, Sao Juliao GP, Vailati BB, Sabbaga J, et al
   Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy.
   Ann Surg. 2019;269:102-107.
   PubMed     Text format     Abstract available
   
   
5. SUNG SY, Jang HS, Kim SH, Jeong JU, et al
   Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.
   Ann Surg. 2019;269:108-113.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

6. KOTHA NV, Kelly KJ
   ASO Author Reflections: Clinical Significance of Primary Tumor Side in Peritoneal Metastatic Colon Cancer.
   Ann Surg Oncol. 2019 Oct 10. pii: 10.1245/s10434-019-07916.
   PubMed     Text format    
   
   
7. VAN WYK HC, Roseweir A, Alexander P, Park JH, et al
   The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
   Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07931.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

8. LI C, He X, Zhang L, Li L, et al
   A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
   BMC Cancer. 2019;19:957.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

9. WU X, Lin H, Li S
   Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
   BMC Gastroenterol. 2019;19:164.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

10. SAHIN IH, Akce M, Alese O, Shaib W, et al
    Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms.
    Br J Cancer. 2019 Oct 14. pii: 10.1038/s41416-019-0599.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

11. JI N, Yang Y, Cai CY, Lei ZN, et al
    Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Cancer Lett. 2019;440-441:82-93.
    PubMed     Text format     Abstract available
    
    
12. VIDIMAR V, Licona C, Ceron-Camacho R, Guerin E, et al
    A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53.
    Cancer Lett. 2019;440-441:145-155.
    PubMed     Text format     Abstract available
    
    
13. KIM YJ, Lee JH, Jin S, Kim JH, et al
    Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.
    Cancer Lett. 2019;440-441:168-179.
    PubMed     Text format     Abstract available
    
    
14. ZHANG Y, Song J, Zhao Z, Yang M, et al
    Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Cancer Lett. 2019 Oct 11. pii: S0304-3835(19)30513.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

15. DURAN-SANCHON S, Moreno L, Auge JM, Serra-Burriel M, et al
    Identification and validation of microRNA profiles in fecal samples for detection of colorectal cancer.
    Gastroenterology. 2019 Oct 14. pii: S0016-5085(19)41439.
    PubMed     Text format     Abstract available
    
    
16. MULLER C, Yurgelun M, Kupfer SS
    Precision Treatment and Prevention of Colorectal Cancer-Hope or Hype?
    Gastroenterology. 2019 Oct 14. pii: S0016-5085(19)41443.
    PubMed     Text format    
    
    
17. RABENECK L, Chiu HM, Senore C
    International Perspective on the Burden of Colorectal Cancer and Public Health Effects.
    Gastroenterology. 2019 Oct 14. pii: S0016-5085(19)41444.
    PubMed     Text format    
    
    

    
    Gut

18. WANG P, Berzin TM, Glissen Brown JR, Bharadwaj S, et al
    Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study.
    Gut. 2019;68:1813-1819.
    PubMed     Text format     Abstract available
    
    
19. KUIPERS EJ, Grobbee EJ
    Personalised screening for colorectal cancer, ready for take-off.
    Gut. 2019 Oct 15. pii: gutjnl-2019-319677. doi: 10.1136/gutjnl-2019-319677.
    PubMed     Text format    
    
    

    
    Int J Cancer

20. MATTIOLI AV, Farinetti A, Gelmini R
    The beneficial effect of Mediterranean diet on colorectal cancer.
    Int J Cancer. 2019;145:306.
    PubMed     Text format    
    
    

    
    J Clin Oncol

21. MODEST DP, Martens UM, Riera-Knorrenschild J, Greeve J, et al
    FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109).
    J Clin Oncol. 2019 Oct 14:JCO1901340. doi: 10.1200/JCO.19.01340.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

22. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

23. GUNJUR A
    Targeted therapy for BRAF-mutant colorectal cancer.
    Lancet Oncol. 2019 Oct 10. pii: S1470-2045(19)30644.
    PubMed     Text format    
    
    

    
    PLoS One

24. SOLIMAN C, Eastwood S, Truong VK, Ramsland PA, et al
    The membrane effects of melittin on gastric and colorectal cancer.
    PLoS One. 2019;14:e0224028.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: